Hemostasis involves a highly regulated equilibrium between pro and anticoagulant processes. It is a dynamic system comprising cellular and plasma factors that interact with damaged vascular tissue to minimize blood loss. Platelets are anucleate cellular fragments derived from mature megakaryocytes via a process called thrombopoiesis (Stegner et al., 2017). They circulate throughout the vascular system in a quiescent discoid form, interacting minimally with healthy endothelial cells. Following injury to the endothelium, platelets serve as key effector cells for the hemostatic response. They rapidly adhere to exposed extracellular matrix via tether receptor complexes such as collagen-glycoprotein (GP) VI and von Willebrand factor-GPIb-V-IX (Canobbio et al., 2004; Chen et al., 2002). Platelet attachment triggers downstream effects including the release of platelet-specific α granules and dense granules (Blair & Flaumenhaft, 2009; Li et al., 2010). Contained within these granules are important membrane bound receptors (GPIIb/IIIa and P-selectin), platelet mediators (adenosine 5ʹ-diphosphate [ADP] and calcium ions; Blair et al., 2009; Sharda & Flaumenhaft, 2018). Release of ADP, a potent platelet agonist, is crucial for the formation of an effective platelet plug. Such ADP mediated activation leads to morphological changes, transforming resting discoid platelets to an amoeboid state with numerous pseudopodia that facilitate platelet interdigitation and stabilize the developing aggregate